McAdam LLC’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
2,782
+700
+34% +$259K 0.04% 158
2026
Q1
$563K Buy
2,082
+374
+22% +$111K 0.03% 226
2025
Q4
$564K Buy
1,708
+287
+20% +$97.3K 0.03% 218
2025
Q3
$490K Buy
1,421
+286
+25% +$86.5K 0.02% 220
2025
Q2
$354K Buy
1,135
+128
+13% +$48.9K 0.02% 257
2025
Q1
$528K Buy
1,007
+27
+3% +$13.8K 0.03% 187
2024
Q4
$496K Buy
980
+221
+29% +$126K 0.03% 206
2024
Q3
$444K Buy
759
+154
+25% +$87.1K 0.02% 207
2024
Q2
$308K Buy
605
+102
+20% +$50K 0.02% 234
2024
Q1
$249K Buy
+503
New +$256K 0.02% 255
2023
Q4
Sell
-403
Closed -$203K 289
2023
Q3
$203K Buy
+403
New +$198K 0.02% 246

Other funds holding UNH

McAdam LLC's UNH Position: Q2 2026 in Review

McAdam LLC increased its UnitedHealth (UNH) stake by 34% in Q2 2026, buying an estimated $259K and bringing the position to 2,782 shares worth $1.16M. The position accounts for 0.04% of the portfolio, ranked #158.

McAdam LLC first reported a position in UNH in Q3 2023 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • McAdam LLC held 2,782 shares of UnitedHealth worth $1.16M as of Q2 2026.
  • McAdam LLC bought 700 UnitedHealth shares in Q2 2026, an estimated $259K.
  • UnitedHealth made up 0.04% of McAdam LLC's portfolio in Q2 2026, its #158 holding.
  • McAdam LLC first reported a position in UnitedHealth in Q3 2023 and has held it in 11 quarters since.
  • 1,867 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.